ANPEP and liver cancer: In a different context, Haraguchi et al. took advantage of human liver cancer cells, HuH7, and PLC/PRF/5, as well as HCC clinical samples, to identify a dormant subpopulation of slow-cycling cells with enriched expression of the CD13 (Aminopeptidase N) marker.